Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Licensing
Sort By
Newest First
1 / 2
1 / 2
Patented Production Strains
Adding Value with Patent Protection for Novel, Tailor-Made Bacterial Production Strains
Trond Erik Vee Aune, Ph.D.
Vectron Biosolutions
PAO-08-022-CL-03
August 16, 2022
Licensing
AstraZeneca Completes Recovery of Global Rights to Brazikumab from Allergan
AstraZeneca
PR-M05-20-NI-019
May 14, 2020
Licensing
LEO Pharma Enters License Agreement with Oneness Biotech and Microbio Shanghai for FB825 a Novel Atopic Dermatitis and Asthma Drug Candidate
LEO Pharma
PR-M04-20-NI-023
April 15, 2020
Licensing and Partnering
Facilitating Pharma Licensing and Partnering
Erica Sosnowski; Adam Sosnowski
Sosna & Co.
PAP-Q1-20-CL-026
March 19, 2020
Legality
Legal Issues in Licensing and M&A
Randy Sunberg
Baker McKenzie
PAP-Q1-20-CL-028
March 19, 2020
Licensing
Five Prime Therapeutics Licenses Antibodies to Seattle Genetics for Use in Novel Antibody Drug Conjugate (ADC) Programs
Five Prime Therapeutics
PR-M02-20-NI-027
February 20, 2020
License Agreement
SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor
SeraNovo
PR-M10-19-NI-046
October 30, 2019
Licensing Agreement
Akcea and Pfizer Inc. Announce Licensing Agreement for Investigative Antisense Therapy Akcea-ANGPTL3-LRX
Pfizer
PR-M10-19-NI-020
October 11, 2019
Licensing
Ionis Licenses Hepatitis B Program to GSK
Ionis Pharmaceuticals, Inc.
PR-M08-19-NI-085
August 29, 2019
Licensing
Harbour BioMed Enters Multi-Year HCAb Technology Licensing Agreement with a Top-Ten Global Pharma for Next Generation Human Antibody Discovery
Harbour BioMed
PR-M05-19-NI-088
May 31, 2019
Collaboration
Lilly and ImmuNext Announce Licensing and Research Collaboration
Eli Lilly and Company
PR-M03-19-NI-086
March 29, 2019
Immuno-Oncology
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million
WuXi Biologics
PR-M02-19-NI-067
February 28, 2019
Drug Development
AbbVie Exercises Option to License Parkinson’s Tech from BioArctic
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M12-18-NI-015
December 19, 2018
License Agreement
Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard
Elysium Health™
PR-M09-18-NI-067
September 21, 2018
Growth Strategy
Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex®
Perrigo
PR-M08-18-NI-117
August 30, 2018
FDA Approval
Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents
Grifols
PR-M05-18-NI-058
May 16, 2018
Licensing
Merck Projected to Spend the Most on Licensing Deals in 2018
Guy Tiene
Nice Insight
PAO-M04-18-NI-003
April 04, 2018
Licensing
Protein Science to Advance Through LenioBio and Dow AgroSciences License Agreement
LenioBio GmbH
PR-M03-18-NI-064
March 19, 2018
Biosimilar
Mylan to Bring a Biosimilar of BOTOX to the Market Through a Collaboration and License agreement with Revance Therapeutics
Mylan N.V.
PR-M03-18-NI-017
March 05, 2018
License Agreement
Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates
Selexis SA
PR-M03-18-NI-009
March 02, 2018
